Literature DB >> 23118654

Why is the platelet count low: should I be concerned about heparin-induced thrombocytopenia?

Christopher Lancaster1, Joseph D Tobias.   

Abstract

Entities:  

Keywords:  adverse effect; heparin; heparin-induced thrombocytopenia; platelet; thrombocytopenia

Year:  2012        PMID： 23118654      PMCID： PMC3428185          DOI： 10.5863/1551-6776-17.1.2

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


× No keyword cloud information.
  48 in total

1.  Cardiovascular surgery without cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II using anticoagulation with recombinant hirudin.

Authors:  A Koster; H Kuppe; G J Crystal; F Mertzlufft
Journal:  Anesth Analg       Date:  2000-02       Impact factor: 5.108

2.  Use of recombinant hirudin in patients with heparin-induced thrombocytopenia with thrombosis requiring cardiopulmonary bypass.

Authors:  P Latham; A F Revelis; G P Joshi; J M DiMaio; M E Jessen
Journal:  Anesthesiology       Date:  2000-01       Impact factor: 7.892

3.  Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin.

Authors:  A Koster; H Kuppe; R Hetzer; R Sodian; G J Crystal; F Mertzlufft
Journal:  Anesthesiology       Date:  1998-09       Impact factor: 7.892

4.  Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy.

Authors:  R E Smith; G E Townsend; B R Berry; T Bowen
Journal:  Ann Pharmacother       Date:  1996-05       Impact factor: 3.154

5.  A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.

Authors:  Linda J Demma; Anne M Winkler; Jerrold H Levy
Journal:  Anesth Analg       Date:  2011-07-25       Impact factor: 5.108

6.  Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.

Authors:  S Gillis; G Merin; D Zahger; M Deeb; B Drenger; E Hyam; A Eldor
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

7.  Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).

Authors:  B R Saxon; M D Black; D Edgell; D Noel; M T Leaker
Journal:  Ann Thorac Surg       Date:  1999-09       Impact factor: 4.330

8.  Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.

Authors:  R R Kanagasabay; M J Unsworth-White; G Robinson; D Bevan; G Farnsworth; E J Haxby; E E Smith
Journal:  Ann Thorac Surg       Date:  1998-08       Impact factor: 4.330

9.  Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.

Authors:  A Greinacher; B Pötzsch; J Amiral; V Dummel; A Eichner; C Mueller-Eckhardt
Journal:  Thromb Haemost       Date:  1994-02       Impact factor: 5.249

10.  Heparin-induced thrombocytopenia in the pediatric population: a review of current literature.

Authors:  Niyati H Vakil; Abir O Kanaan; Jennifer L Donovan
Journal:  J Pediatr Pharmacol Ther       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.